Procter & Gamble Health

Company Description

Procter & Gamble Health Limited is an India-based multinational consumer goods company focused on manufacturing and marketing over-the-counter products, vitamins, minerals, and supplements for a healthy lifestyle. The company operates in healthcare, with brands including Polybion, Cosome, Evion, Neurobion, Seven Seas, Nasivion, and Livogen. Its products are sold in about 180 countries and territories throughout the world. In the last fiscal year, the company had 1336 employees, a market cap of $1130 millions, profits of $90 millions, and revenue of $138 millions.

Analysis

ANALYSIS: With an Obermatt 360° View of 17 (better than 17% compared with alternatives), overall professional sentiment and financial characteristics for the stock Procter & Gamble Health are critical, mostly below average. The 360° View is based on consolidating four consolidated indicators, with half of the metrics below and half above average for Procter & Gamble Health. The consolidated Growth Rank has a good rank of 83, which means that the company experiences above-average growth momentum when looking at financial metrics such as revenue, profit, and invested capital growth as well as stock returns. This means that growth is higher than for 83% of competitors in the same industry. In addition, the consolidated Safety Rank has a safer rank of 75 which means that the company has a financing structure that is safer than 75% comparable companies when looking at the amount of its debt, its refinancing requirements, and its ability to service debt. But the consolidated Value Rank has a less desirable rank of 11 which means that the share price of Procter & Gamble Health is on the higher side compared with typical size in indicators such as revenues, profits, and invested capital. This means that the stock price is higher than for 89% of alternative stocks in the same industry. The consolidated Sentiment Rank also has a low rank of 20, which means that professional investors are more pessimistic about the stock than for 80% of alternative investment opportunities. ...read more

Country

India

Industry Pharmaceuticals

Size Small

Website pghealthindia.com

Index

Add to Watchlist

See Similar Stocks

Make Sense of the Ranks

The higher, the better. For every stock, we judge its performance against its peers and rank it on a scale of 1 to 100. These ranks are percentiles: a rank of 75 means the company outperforms 75% of its peers in that specific area. The higher the rank, the better the stock stacks up against its peers.

Detailed and Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history. Unlock the analysis.